diagnostics.ai News
4 articles
growth-positive
https://www.jpost.com/HEALTH-SCIENCE/Israeli-researchers-develop-innovative-diagnostic-method-for-coronavirus-621617
British company diagnostics.ai, which conducts its research and development in Herzliya, Israel, is providing labs in the UK and US with an advanced diagnostic technique that uses artificial intelligence for faster and more accurate results. The companys technology is generic, meaning it can analyze any virus or bacteria. Once a biological specimen is analyzed, which takes 40 minutes to an hour, the results are almost instantaneous. The technology was studied by the West of Scotland Specialist Virology Centre and found to be superior in terms of accuracy. The company is planning to use it for cancer and genetic expressions and any other form of testing to analyze material containing DNA or RNA.
CustomersExpand
growth-positive
Viapath Implementing diagnostics.ai to Automate and Digitise Their Molecular Diagnostics
Viapath, one of the largest pathology service providers in the UK, has agreed to implement diagnostics.ais unique artificial intelligence (AI) technology. The technology automates the analysis and reporting of results, improving accuracy and standardization. The implementation will begin in February 2018 at Viapaths South London Specialist Virology Centre. The partnership with diagnostics.ai demonstrates Viapaths commitment to setting the standard for the future of pathology.
Partners
growth-positive
diagnostics.ai Win Digital Health 2017 Award for 'Best Data-Driven Innovation'
Diagnostics.ai, formerly known as Azure PCR Ltd, has won the Digital Health 2017 award for best data-driven innovation. The companys technology uses machine learning to automate precision molecular diagnostics, reducing time and cost of testing while increasing accuracy. The technology is capable of identifying any pathogen, cancer, or genetic disease based on disease-causing genes. Diagnostics.ai is working with NHS partners in the UK and is poised to scale up and roll out its technology to labs, hospitals, healthcare centers, doctors, and pharmacists. The companys achievement was praised by the judges for its wide range of tests and applications. The award was presented in collaboration with the UKs Digital Catapult.
CustomersPartners
growth-positive
The instant test that lets you diagnose your illness
Azure PCR, a Jerusalem-based subsidiary, has developed disruptive technology for detecting, diagnosing, and tracking infectious diseases. The companys automatic DNA analysis technology is being used in major global collaborations, such as the Johns Hopkins-based PERCH study, to curb the spread of viruses in real time. Azure PCRs automated analysis process eliminates the need for skilled personnel and provides standardized results. The company aims to improve access to molecular diagnostics and increase the speed and accuracy of disease detection and treatment.
PartnersCustomers
